NIH Clinical Trials
ClinicalTrials.gov offers up-to-date information for locating federally and privately supported clinical trials for a wide range of diseases and conditions. A clinical trial (also clinical research) is a research study in human volunteers to answer specific health questions. Interventional trials determine whether experimental treatments or new ways of using known therapies are safe and effective under controlled environments. Observational trials address health issues in large groups of people or populations in natural settings.
ClinicalTrials.gov currently contains 131,478 trials sponsored by the National Institutes of Health, other federal agencies, and private industry. Studies listed in the database are conducted in all 50 States and in 179 countries and it receives over 50 million page views per month 65,000 visitors daily.
To review studies focused on vasculitis, enter the word “vasculitis” or the specific vasculitic disease in the Search box in the upper right hand corner.
Below is is a list of NIH Clinical Trials related to “vasculitis” last updated (includes received) in the last 30 days:
- A Registry Study on Biomarkers of Takayasu's Arteritis (ARSBTA)
- Induction Therapy With Anti-TNFα vs Cyclophosphamide in Severe Behçet Disease
- The Effect of Prednisone on Atherogenesis as Studied in the Macrophage Foam Cell Formation Model System.
- Velocimetric Study of Temporal Arteries in Patients With Horton Disease Using Scan-Doppler
- Maintaining or Stopping Immunosuppressive Therapy in Patients With ANCA Vasculitis and End-stage Renal Disease
- A Study to Evaluate the Efficacy of Tocilizumab as a Remission-Induction and Glucocorticoid-Sparing Regimen in Subjects With New-Onset Polymyalgia Rheumatica (PMR- SPARE)
- Efficacy and Safety Study of Sirukumab in Subjects With Polymyalgia Rheumatica
- Cohort Study on Traditional Chinese Medicine Diagnosis and Treatment of Children With Henoch-Schonlein Purpura Nephritis
- Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients
- 1 Year Canakinumab Treatment in Behcet's Disease Patients With Neurologic or Vascular Involvement